GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Asset Impairment Charge

Jianmin Pharmaceutical Group Co (SHSE:600976) Asset Impairment Charge : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co Asset Impairment Charge?

Jianmin Pharmaceutical Group Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Jianmin Pharmaceutical Group Co Asset Impairment Charge Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co Asset Impairment Charge Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Jianmin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Jianmin Pharmaceutical Group Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Jianmin Pharmaceutical Group Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Jianmin Pharmaceutical Group Co (SHSE:600976) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » Asset Impairment Charge
Comparable Companies
SZSE:000915 SZSE:002219 SZSE:000756 SHSE:600812 SZSE:002038 SHSE:600195 SHSE:688321 SHSE:600252 SZSE:002424 SZSE:000650 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Website
http://www.whjm.com
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.

Jianmin Pharmaceutical Group Co (SHSE:600976) Headlines

No Headlines